Susquehanna International Group Ltd. Evogene Ltd. Transaction History

Susquehanna International Group Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$0.7 - $0.98 $9,324 - $13,054	13,321 New	13,321 $9,000
Q2 2022 Aug 15, 2022	SELL	$0.75 - $1.33 $2,514 - $4,458	-3,352 Reduced 10.45%	28,718 $21,000
Q1 2022 May 16, 2022	BUY	$1.09 - $1.83 $345 - $580	317 Added 1.0%	32,070 $42,000
Q4 2021 Feb 14, 2022	SELL	$1.63 - $2.83 $17,592 - $30,544	-10,793 Reduced 25.37%	31,753 $55,000
Q3 2021 Nov 15, 2021	BUY	$2.45 - $3.45 $35,287 - $49,690	14,403 Added 51.18%	42,546 $113,000
Q2 2021 Aug 11, 2021	BUY	$3.3 - $5.02 $92,871 - $141,277	28,143 New	28,143 $96,000

117K

Ticker EVGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,202,000
Market Cap $69.6M
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group Ltd., based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group Ltd. with notifications on news.